← Back to Search

Behavioural Intervention

Apollo Wearable System for Post-Traumatic Stress Disorder (Apollo PTSD Trial)

Phase 2
Waitlist Available
Research Sponsored by Lisa Brenner
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 +/- 2 weeks
Awards & highlights

Apollo PTSD Trial Summary

This trial will test a new medical device called the Apollo in a group of Veterans. They will also collect data about how the device affects the body.

Apollo PTSD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 +/- 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 +/- 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability via Client Satisfaction Questionnaire (CSQ)
Acceptability via Credibility Scale
Acceptability via Expectancy Scale
+5 more

Apollo PTSD Trial Design

1Treatment groups
Experimental Treatment
Group I: Single Arm- Apollo Wearable SystemExperimental Treatment1 Intervention
Apollo Device TVS (10-200 Hz) attached to the subject's wrist or ankle via a commercially available wearable vibration technology can deliver TVS (Transcutaneous Vibratory Stimulation). The intensity will be targeted for the sensory threshold (the level at which the vibration is just noticeable) as this is where the TVS seems to be most effective from prior studies. Similar vibratory stimuli have been demonstrated to be safe in the literature.10-14 The intensity of the vibration will be adjusted to the subjects' comfort and can be controlled by the subject at any time.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Apollo Wearable System
2022
Completed Phase 2
~70

Find a Location

Who is running the clinical trial?

Apollo NeuroscienceUNKNOWN
1 Previous Clinical Trials
25 Total Patients Enrolled
Lisa BrennerLead Sponsor
1 Previous Clinical Trials
44 Total Patients Enrolled

Media Library

Apollo Wearable System (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05019651 — Phase 2
Post-Traumatic Stress Disorder Research Study Groups: Single Arm- Apollo Wearable System
Post-Traumatic Stress Disorder Clinical Trial 2023: Apollo Wearable System Highlights & Side Effects. Trial Name: NCT05019651 — Phase 2
Apollo Wearable System (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05019651 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any specific medical criteria that would make a person ineligible for this research?

"This study is seeking around 100 individuals that suffer from PTSD and are aged 18-65."

Answered by AI

Does this research project restrict its participants to those who are under 65 years old?

"The target population for this trial are individuals who are over 18 but have not yet reached 65 years of age."

Answered by AI

Are there any openings for volunteers in this research project?

"Yes. The clinical trial, which was originally posted on February 1st, is currently looking for 100 patients from 1 site, according to the data on clinicaltrials.gov."

Answered by AI

Are there any health concerns associated with the Apollo wearable device?

"The Apollo Wearable System is still being tested for efficacy, but there is already some evidence supporting its safety. Our team gives it a 2."

Answered by AI

Who else is applying?

What state do they live in?
Colorado
North Carolina
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
Eastern Colorado Health Care System (ECHCS)
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

Dealing with mental challenges of PTSD.
PatientReceived 1 prior treatment

How responsive is this trial?

Average response time
  • < 2 Days
Typically responds via
Phone Call
Most responsive sites:
  1. Eastern Colorado Health Care System (ECHCS): < 48 hours
Recent research and studies
clinicaltrials.govStudy
Acceptability and Feasibility of Apollo in Veterans With a History of PTSD
Lisa Brenner 2022. "Acceptability and Feasibility of Apollo in Veterans With a History of PTSD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05019651.
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top